Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » CareDx Q3 Revenues Up 58 Percent

CareDx Q3 Revenues Up 58 Percent

Oct 29, 2020
|
staff reporter

NEW YORK – CareDx reported after the close of the market on Thursday that its third quarter revenues rose 58 percent year over year, thanks largely to a 61 percent increase in testing services revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mouse Vision Restored

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

Side Effect Suit in India

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

Kids' Vaccine Trial Planned

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

Nature Papers Present Tool for Targeted Nanopore Sequencing, Crop Genetic Diversity, More

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.

What's Popular?

In Business News

  1. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  2. Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies

  3. Swedish Sequencing Firm Single Technologies Raises $6.1M

  4. NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

    Premium

  5. Twist Bioscience Proposes $250M Public Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.